Summary.-Studies have been carried out into the effect usually referred to as " repair of potentially lethal damage " following the treatment of cells with bleomycin.
In vitro, increased survival was seen with delayed subculture of cells in both exponential phase and plateau phase. It was unimportant whether the medium present during the delay period had been previously used to support cell growth. Exposure of cells growing as a solid tumour in vivo to bleomycin (4 mg/kg), gave a surviving fraction of 2 x 10-3 if assay was carried out at 30 min but a surviving fraction of virtually 100% if assay was delayed until 6 h.
Various possible artefacts have been eliminated as reasons for the observations but doubts are raised regarding the nature of the mechanism involved.
AN EFFECT usually referred to as "repair of potentially lethal damage" (PLD) following treatment of cells with bleomycin (BLM) has been demonstrated both in vitro Barranco, Novak and Humphrey, 1975) and in vivo Twentyman and Bleehen, 1974; Takabe et al., 1974) . After treatment with BLM, delay in preparation of a single cell suspension is associated with a reduction in the killing effect seen when trypsinization is carried out immediately after exposure to BLM. In this paper we report the results of our further investigations into this phenomenon.
AIATERIALS AND METHODS
Bleomycin was kindly supplied by Lundbeck Ltd. The drug was dissolved in sterile water and stored at -20°C. Immediately before use the solution was thawed, diluted in sterile Hanks' solution and either added directly to the growth medium of cells in vitro in a volume of between 0-05 and 0-2 ml or else injected into tumour bearing mice. In most experiments, mice received * Present ad(lress: MI.R.C. Clinical Oiicology and Road, Cambridge. the drug by the intraperitoneal route in a volume of 0-5 ml. When intravenous administration was required, a volume of 025 ml was used.
The EMT6 cell line will grow either as a monolayer in vitro or as a solid tumour in mice of the BALB c strain (Rockwell, Kallman and Fajardo, 1972) . In addition, assay of cell survival following treatment in vivo may be carried out by in vitro plating.
Our continuous culture subline EMT6/M/ CC and its growth conditions have been described previously were carried out as previously described . Where trypsinization was to be delayed, a double rinse with minimal medium was given and the appropriate delay medium added to the flask. If this medium had previously been used for cell growth it was centrifuged for 10 min at 3000 rev/min and passed through a 0-2 Hum Millipore filter before use.
Cells to be treated with BLM in suspension were trypsinized from a control flask immediately before the experiment. After treatment, the cells were spun down at 1000 rev/min for 5 min, washed twice in fresh medium and spun down each time, and then finally counted and diluted before plating.
Early experiments on the EMT6 solid tumour were carried out on a subline designated EMT6/M/AC which has been fully described by Watson (1975) . Most of these experiments, however, were carried out on a different subline designated EMT6/VJ/AC, kindly supplied by Dr E. Frindel, which differs in its growth rate and morphological characteristics. Experiments were carried out between 10 and 13 days after inoculation of 4 x 104 cells (corresponding to a tumour size of 200 mm3). Groups of 3 tumours were used except where otherwise stated.
Solid tumours were excised and single cell suspensions were produced as previously described . The method was modified in that, following 20 min agitation of tumour fragments in Hanks' solution with added trypsin, 5 ml of complete medium was added in order to inactivate the trypsin. Centrifugation was then carried out at room temperature. In experiments designed to examine the repair of PLD in solid tumours maintained in vitro, the tumours were divided into pieces immediately after excision. Those pieces intended for delayed disaggregation were placed into universal containers containing 5 ml of complete medium and then maintained at either 37°C or kept on melting ice for the appropriate period.
Where single cell suspensions were required without the use of trypsin, the chopped tumour was agitated in Hanks' solution for 5 min at 37°C and then filtered through fine wire gauze. This resulted in a suspension with a low viability based on trypan blue staining (20-30%) but a good yield of single tumour cells.
Tumour growth experiments were carried out by the intradermal inoculation of the appropriate number of tumour cells in 0 05 ml of Hanks' solution and subsequent caliper measurements. culture, however, a temperature of 37°C was maintained, as the medium used for rinsing and during the delay period was kept at 37°C until just before use. We therefore investigated whether the drop in temperature could be responsible for the lower survival with immediate subculture. Cells from flasks trypsinized immediately after drug exposure were, after resuspension, divided into 3 aliquots and kept either at 37°C or 22°C or 0°C for the 30 min during counting, dilution and plating, before being returned to the incubator in the cloning dishes. Flasks for delayed trypsinization were, after medium change, kept at 37°C, 22°C or 0°C for 30 min, before being returned to the incubator for the remaining 90 min delay period. The results for exponential phase cells exposed to BLM (50 ,ug/ml) for 1 h, with 2 h delayed subculture where appropriate, are shown in Table III 
RESULTS

In vitro
Delay in vitro
The effects of keeping either pieces of solid tumour or a cell suspension at either 370C or 00C in medium in vitro after removal of the tumour at 30 min after BLM are shown in Fig. 3 appears that the ability to increase surviving fraction may be "stored" at 00C.
Inoculation of new tumours
To ensure that the large difference in surviving fraction between cells cloned shortly after exposure to BLM and cells taken at later times is not an artefact of the cell culture procedure, we looked at the growth of tumours in mice given cells taken from treated animals. The growth of tumours in groups of 10 recipient mice are shown in Fig. 4 (Whitmore and Gulyas, 1967) and incubation in a balanced salt solution (Belli and Shelton, 1969) have all been found to increase the surviving fraction if applied after irradiation. On the other hand, Phillips and Tolmach (1966) have found that post-irradiation treatment with inhibitors of DNA synthesis or exposure to 29°C cause a decrease in surviving fraction. The term "potentially lethal damage" has been used by Phillips and Tolmach (1966) to refer to damage which may be repaired under some circumstances but which is able to lead to cell death given certain post-irradiation conditions which by themselves have no effect on the survival of control cells. Hahn and Little (1972) pointed out that conditions leading to increased survival following irradiation were those associated with a slowing down of the normal progression of cells through their life cycle. These workers then went on to examine the relative ability to repair radiation induced PLD of cells in the exponential and plateau phases of growth. In exponential phase, where the cells are almost all in a rapid state of proliferation, the radiation survival was the same whether the cells were subcultured immediately after irradiation or left in the original monolayer for several hours before subculture. On the other hand, crowded cultures in the plateau phase, where the amount of proliferation is greatly reduced, showed a considerable increase in surviving fraction if allowed to remain in the crowded state following irradiation than if immediately subcultured. Hahn and Little (1972) attributed this finding to the fact that cells in crowded cultures had more time to repair PLD before fixation of damage had occurred. The amount of PLD was greater at lower survival levels and this led to a reduction in the slope of the survival curve.
Subsequently, Little et al. (1973) were able to demonstrate a similar effect in vivo either in a crowded ascites tumour or a solid tumour in the mouse. The effect could not, however, be seen in the ascites tumour during exponential growth. Repair of PLD following drug treatment has been investigated in vitro by . In this study repair of PLD occurred in both exponential and plateau phase cells folowing treatment with 5-FU, but only in plateau phase following treatment with bleomycin. Subsequently, however, using a different cell line, Barranco et al. (1975) showed repair of PLD following bleomycin treatment both in exponential and plateau phases. In vivo, Hahn et al. (1973) showed repair of PLD in the EMT6 mouse tumour following treatment with cyclophosphamide, 5-fluorouracil and bleomycin. We were able to confirm that BLM damage is repaired in solid EMT6 tumours over a wide range of sizes .
The studies described in the present paper add information on several aspects of this problem. We find that cells are able to repair PLD in exponential, early and late plateau phases, and to approximately the same extent from the same surviving fraction. Thus, the rate of proliferation of the treated cells does not, in our work, appear to be a crucial factor. Furthermore, the source of medium used during the subculture delay period does not seem to be an important factor, although our previous studies have shown that medium from plateau cultures is less able to support cell growth than exponential phase medium. This is in contrast to the finding by Little (1971) that conditioned medium can enhance the repair of PLD in irradiated cells. We have also shown that when cells are re-inoculated into flasks shortly before the experiment, PLD repair still occurs, thus ruling out local cell crowding as a factor. In addition, the possibility of an artefact due to temperature changes during subculture has been ruled out.
Our results in vivo show that the effect of PLD repair can be very much greater than has previously been described. Whereas Hahn et al. (1973) Barranco and Humphrey (1971) that, in addition to killing cells, BLM also induces a progression delay in the cell cycle. This delay could possibly allow repair of BLM lesions which would have been lethal if progression had continued unaltered. It would, however, be necessary to also show that the subculturing procedure was able to remove the progression delay, whilst medium change was not. We know of no evidence to support this. Studies by Schiaffini (unpublished data) have shown that repair of PLD following BLM treatment of Chinese hamster cells in vitro follows the same time course as rejoining of DNA strand breaks induced by BLM, with possible implications regarding the nature of the repair processes. Autoradiographic work by Fujimoto (1974) has shown that if 14C labelled BLM is administered to mice bearing an ascites tumour, then the label is almost all at the cell surface at 2 h, has passed to the nuclear membrane by 4 h and visible necrosis sets in between 4 and 8 h. This may imply that BLM exerts a lethal effect on cells only if allowed a considerable period of time to enter the cell, having initially become absorbed on to the cell membrane. For this to explain the PLD story would require that some aspect of the subculturing procedure increased the rate of entry of BLM into the cell. Having ruled out the use of trypsin as the vital factor, at least in vivo, one is left with the possibility that any procedure, including mechanical disaggregation, is sufficiently traumatic that the membrane is damaged.
Another factor which requires explanation is the apparent discrepancy between the in vivo sensitivity if measured at 30 min and the in vitro sensitivity. One possible explanation is that the cell membrane is much more permeable to BLM when in the in vivo environment and that this permeability is lost when the tumour is made into a cell suspension and then exposed to the drug. It seems unlikely, however, that exposure to trypsin could cause this loss of permeability because the sensitivity of in vitro cells is similar when exposed to BLM either before or after trypsinization. An alternative explanation is that BLM is converted in vivo to a more active form. It does appear, however, that permeability of the cell membrane is a very important factor in determining the sensitivity of cells to BLM. It has been shown that the action of the antifungal polyene, pentamycin, which increases membrane permeability, can markedly increase the ability of BLM to inhibit DNA and RNA synthesis in cells (Nakashima et al., 1974) . Our own unpublished studies with pentamycin indicate that its use can increase by 100-fold the cell killing effect of BLM.
The balance of available evidence would therefore indicate that some aspect of the subculture procedure, as yet undetermined, either allows more BLM to enter the cell or else inhibits the repair of BLM damage. If the former explanation is the correct one, it may be that the phenomenon of PLD repair is really only an artefact induced by the procedure of making cell suspensions and has no significance with regard to cellular repair mechanisms. It would, however, leave open the possibility that manipulation of membrane permeability by other agents could be used to increase the efficacy of BLM. If, on the other hand, PLD repair does involve intracellular repair processes, then the possibility arises that BLM effectiveness could be increased by the combined use with agents known to act, in one way or another, as inhibitors of various types of repair. We are currently investigating these possibilities.
In this discussion, we have used the expression "repair of potentially lethal damage" in accordance with the usage which has become common over the last few years. At our present state of knowledge, however, it is in many ways an unfortunate expression in that it carries possible implications regarding mechanisms that are generally unjustified. In the absence of specific information regarding the nature of the damage sustained by cells, and evidence that repair of such damage is responsible for the increased survival with delayed trypsinization, great caution must be exercised. Furthermore, whilst increased survival with delayed trypsinization may be observed following exposure to both drugs and to x-rays, there is no necessity that the same mechanism be involved in both instances.
It is very clear from our results that in a situation where a tumour is treated in vivo and subsequently assayed in vitro, the result obtained can be extremely dependent upon the time after treatment at which the tumour is excised. It would appear therefore that any investigation of tumour response based on this type of assay should always include a careful investigation of the significance of this factor.
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